US Stock MarketDetailed Quotes

Castle Biosciences (CSTL)

Watchlist
  • 19.130
  • +0.250+1.32%
Close May 15 16:00 ET
  • 19.130
  • 0.0000.00%
Post 16:04 ET
580.21MMarket Cap-45.55P/E (TTM)

Castle Biosciences (CSTL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-266.62%-22.13M
-0.80%64.35M
10.53%26.93M
-3.03%22.63M
-13.24%20.82M
11.69%-6.04M
1,252.97%64.87M
31.09%24.37M
365.64%23.34M
733.86%24M
Net income from continuing operations
43.82%-14.52M
-232.41%-24.16M
-124.32%-2.33M
-122.08%-501K
-49.29%4.52M
-920.05%-25.85M
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
Operating gains losses
-241.89%-2.02M
-164.14%-1.47M
----
----
----
--1.43M
---555K
----
----
----
Depreciation and amortization
-86.80%3.93M
154.87%40.77M
-34.52%3.78M
7.77%3.82M
1.97%3.41M
791.14%29.76M
29.74%16M
78.91%5.77M
11.56%3.54M
10.13%3.35M
Deferred tax
98.70%-10K
-544.54%-6.23M
60.68%-907K
-97.79%116K
-202.66%-4.67M
---770K
728.25%1.4M
-877.54%-2.31M
--5.25M
---1.54M
Other non cash items
1,673.33%532K
-42.91%153K
-315.00%-129K
-49.60%63K
296.88%189K
-83.24%30K
-57.80%268K
-82.91%60K
76.06%125K
-4,900.00%-96K
Change In working capital
5.02%-19.36M
196.29%13.6M
604.44%13.97M
1,382.35%11.5M
345.08%8.51M
-8.43%-20.38M
-113.05%-14.13M
-74.13%1.98M
127.69%776K
1,149.67%1.91M
-Change in receivables
120.61%1.08M
154.39%6.88M
915.60%6.27M
144.92%1.91M
216.44%3.91M
-22.41%-5.22M
15.32%-12.64M
33.19%-769K
26.67%-4.25M
6.59%-3.36M
-Change in inventory
-116.10%-207K
-1,009.84%-2.14M
-2.62%-1.6M
-121.30%-307K
-312.23%-1.52M
333.00%1.29M
95.13%-193K
28.07%-1.56M
309.38%1.44M
77.01%-368K
-Change in prepaid assets
-98.19%-6.67M
52.36%-544K
643.20%3.99M
111.62%161K
-597.38%-1.33M
-3,166.02%-3.36M
-162.53%-1.14M
17.51%537K
-31.90%-1.39M
-123.52%-191K
-Change in payables and accrued expense
-2.21%-13.23M
2,290.05%9.68M
52.63%5.48M
83.00%9.62M
42.00%7.52M
11.27%-12.94M
-103.56%-442K
-65.23%3.59M
29.60%5.26M
12.48%5.3M
-Change in other current assets
-141.62%-159K
-36.49%1.01M
-92.87%44K
113.01%311K
-62.27%269K
253.70%382K
369.39%1.58M
35.01%617K
129.44%146K
159.47%713K
-Change in other current liabilities
67.30%-172K
1.09%-1.28M
50.94%-209K
54.29%-197K
-88.46%-343K
-110.40%-526K
-251.29%-1.29M
-76.76%-426K
-419.26%-431K
-117.74%-182K
Cash from discontinued investing activities
Operating cash flow
-266.62%-22.13M
-0.80%64.35M
10.53%26.93M
-3.03%22.63M
-13.24%20.82M
11.69%-6.04M
1,252.97%64.87M
31.09%24.37M
365.64%23.34M
733.86%24M
Investing cash flow
Cash flow from continuing investing activities
-15.03%-25.8M
-20.40%-60.37M
53.05%8.83M
-24.34%-18.39M
-32.50%-28.38M
-13.86%-22.43M
-209.81%-50.14M
175.21%5.77M
-52.34%-14.79M
-39.19%-21.42M
Net PPE purchase and sale
-163.12%-12.45M
-27.09%-35.98M
5.04%-7.18M
-132.43%-14.82M
-76.98%-9.25M
48.28%-4.73M
-108.02%-28.31M
-99.47%-7.56M
-159.85%-6.37M
-29.64%-5.23M
Net business purchase and sale
----
---18.73M
----
----
----
----
--0
----
----
----
Net investment purchase and sale
24.55%-13.36M
109.25%2.02M
77.75%23.69M
57.53%-3.57M
97.52%-401K
-67.71%-17.7M
-747.73%-21.83M
443.38%13.33M
-15.99%-8.42M
-42.58%-16.19M
Net other investing changes
----
---7.68M
--11.04M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-15.03%-25.8M
-20.40%-60.37M
53.05%8.83M
-24.34%-18.39M
-32.50%-28.38M
-13.86%-22.43M
-209.81%-50.14M
175.21%5.77M
-52.34%-14.79M
-39.19%-21.42M
Financing cash flow
Cash flow from continuing financing activities
-224.08%-5.03M
-213.37%-6.96M
14.78%-4.59M
-209.67%-919K
140.48%101K
-114.59%-1.55M
367.15%6.14M
-63.33%-5.39M
1,762.22%838K
-81.42%42K
Net issuance payments of debt
7.69%-24K
-99.24%75K
-3.85%-27K
-29.17%-31K
1,545.45%159K
-100.26%-26K
7,073.94%9.9M
27.78%-26K
33.33%-24K
68.57%-11K
Proceeds from stock option exercised by employees
60.83%1.59M
-7.52%4.62M
175.10%2.81M
-86.22%297K
-20.51%531K
-14.38%988K
67.83%5M
35.28%1.02M
512.50%2.16M
-15.97%668K
Net other financing activities
-162.35%-6.6M
-33.04%-11.66M
-15.50%-7.37M
8.42%-1.19M
4.23%-589K
-430.59%-2.52M
-70.67%-8.76M
-58.88%-6.38M
-377.49%-1.29M
-15.17%-615K
Cash from discontinued financing activities
Financing cash flow
-224.08%-5.03M
-213.37%-6.96M
14.78%-4.59M
-209.67%-919K
140.48%101K
-114.59%-1.55M
367.15%6.14M
-63.33%-5.39M
1,762.22%838K
-81.42%42K
Net cash flow
Beginning cash position
-2.49%116.73M
21.11%119.71M
-9.90%85.56M
-3.90%82.23M
8.13%89.69M
21.11%119.71M
-19.61%98.84M
4.10%94.96M
-10.75%85.57M
-27.76%82.95M
Current changes in cash
-76.43%-52.97M
-114.28%-2.98M
25.95%31.17M
-64.60%3.32M
-384.25%-7.46M
-88.90%-30.02M
186.56%20.87M
224.89%24.75M
301.83%9.39M
113.84%2.62M
End cash Position
-28.91%63.76M
-2.49%116.73M
-2.49%116.73M
-9.90%85.56M
-3.90%82.23M
8.13%89.69M
21.11%119.71M
21.11%119.71M
4.10%94.96M
-10.75%85.57M
Free cash flow
-220.94%-34.58M
-22.48%28.33M
17.56%19.75M
-54.03%7.8M
-38.42%11.56M
32.60%-10.78M
289.85%36.54M
13.55%16.8M
563.28%16.96M
339.98%18.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -266.62%-22.13M-0.80%64.35M10.53%26.93M-3.03%22.63M-13.24%20.82M11.69%-6.04M1,252.97%64.87M31.09%24.37M365.64%23.34M733.86%24M
Net income from continuing operations 43.82%-14.52M-232.41%-24.16M-124.32%-2.33M-122.08%-501K-49.29%4.52M-920.05%-25.85M131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M
Operating gains losses -241.89%-2.02M-164.14%-1.47M--------------1.43M---555K------------
Depreciation and amortization -86.80%3.93M154.87%40.77M-34.52%3.78M7.77%3.82M1.97%3.41M791.14%29.76M29.74%16M78.91%5.77M11.56%3.54M10.13%3.35M
Deferred tax 98.70%-10K-544.54%-6.23M60.68%-907K-97.79%116K-202.66%-4.67M---770K728.25%1.4M-877.54%-2.31M--5.25M---1.54M
Other non cash items 1,673.33%532K-42.91%153K-315.00%-129K-49.60%63K296.88%189K-83.24%30K-57.80%268K-82.91%60K76.06%125K-4,900.00%-96K
Change In working capital 5.02%-19.36M196.29%13.6M604.44%13.97M1,382.35%11.5M345.08%8.51M-8.43%-20.38M-113.05%-14.13M-74.13%1.98M127.69%776K1,149.67%1.91M
-Change in receivables 120.61%1.08M154.39%6.88M915.60%6.27M144.92%1.91M216.44%3.91M-22.41%-5.22M15.32%-12.64M33.19%-769K26.67%-4.25M6.59%-3.36M
-Change in inventory -116.10%-207K-1,009.84%-2.14M-2.62%-1.6M-121.30%-307K-312.23%-1.52M333.00%1.29M95.13%-193K28.07%-1.56M309.38%1.44M77.01%-368K
-Change in prepaid assets -98.19%-6.67M52.36%-544K643.20%3.99M111.62%161K-597.38%-1.33M-3,166.02%-3.36M-162.53%-1.14M17.51%537K-31.90%-1.39M-123.52%-191K
-Change in payables and accrued expense -2.21%-13.23M2,290.05%9.68M52.63%5.48M83.00%9.62M42.00%7.52M11.27%-12.94M-103.56%-442K-65.23%3.59M29.60%5.26M12.48%5.3M
-Change in other current assets -141.62%-159K-36.49%1.01M-92.87%44K113.01%311K-62.27%269K253.70%382K369.39%1.58M35.01%617K129.44%146K159.47%713K
-Change in other current liabilities 67.30%-172K1.09%-1.28M50.94%-209K54.29%-197K-88.46%-343K-110.40%-526K-251.29%-1.29M-76.76%-426K-419.26%-431K-117.74%-182K
Cash from discontinued investing activities
Operating cash flow -266.62%-22.13M-0.80%64.35M10.53%26.93M-3.03%22.63M-13.24%20.82M11.69%-6.04M1,252.97%64.87M31.09%24.37M365.64%23.34M733.86%24M
Investing cash flow
Cash flow from continuing investing activities -15.03%-25.8M-20.40%-60.37M53.05%8.83M-24.34%-18.39M-32.50%-28.38M-13.86%-22.43M-209.81%-50.14M175.21%5.77M-52.34%-14.79M-39.19%-21.42M
Net PPE purchase and sale -163.12%-12.45M-27.09%-35.98M5.04%-7.18M-132.43%-14.82M-76.98%-9.25M48.28%-4.73M-108.02%-28.31M-99.47%-7.56M-159.85%-6.37M-29.64%-5.23M
Net business purchase and sale -------18.73M------------------0------------
Net investment purchase and sale 24.55%-13.36M109.25%2.02M77.75%23.69M57.53%-3.57M97.52%-401K-67.71%-17.7M-747.73%-21.83M443.38%13.33M-15.99%-8.42M-42.58%-16.19M
Net other investing changes -------7.68M--11.04M----------------------------
Cash from discontinued investing activities
Investing cash flow -15.03%-25.8M-20.40%-60.37M53.05%8.83M-24.34%-18.39M-32.50%-28.38M-13.86%-22.43M-209.81%-50.14M175.21%5.77M-52.34%-14.79M-39.19%-21.42M
Financing cash flow
Cash flow from continuing financing activities -224.08%-5.03M-213.37%-6.96M14.78%-4.59M-209.67%-919K140.48%101K-114.59%-1.55M367.15%6.14M-63.33%-5.39M1,762.22%838K-81.42%42K
Net issuance payments of debt 7.69%-24K-99.24%75K-3.85%-27K-29.17%-31K1,545.45%159K-100.26%-26K7,073.94%9.9M27.78%-26K33.33%-24K68.57%-11K
Proceeds from stock option exercised by employees 60.83%1.59M-7.52%4.62M175.10%2.81M-86.22%297K-20.51%531K-14.38%988K67.83%5M35.28%1.02M512.50%2.16M-15.97%668K
Net other financing activities -162.35%-6.6M-33.04%-11.66M-15.50%-7.37M8.42%-1.19M4.23%-589K-430.59%-2.52M-70.67%-8.76M-58.88%-6.38M-377.49%-1.29M-15.17%-615K
Cash from discontinued financing activities
Financing cash flow -224.08%-5.03M-213.37%-6.96M14.78%-4.59M-209.67%-919K140.48%101K-114.59%-1.55M367.15%6.14M-63.33%-5.39M1,762.22%838K-81.42%42K
Net cash flow
Beginning cash position -2.49%116.73M21.11%119.71M-9.90%85.56M-3.90%82.23M8.13%89.69M21.11%119.71M-19.61%98.84M4.10%94.96M-10.75%85.57M-27.76%82.95M
Current changes in cash -76.43%-52.97M-114.28%-2.98M25.95%31.17M-64.60%3.32M-384.25%-7.46M-88.90%-30.02M186.56%20.87M224.89%24.75M301.83%9.39M113.84%2.62M
End cash Position -28.91%63.76M-2.49%116.73M-2.49%116.73M-9.90%85.56M-3.90%82.23M8.13%89.69M21.11%119.71M21.11%119.71M4.10%94.96M-10.75%85.57M
Free cash flow -220.94%-34.58M-22.48%28.33M17.56%19.75M-54.03%7.8M-38.42%11.56M32.60%-10.78M289.85%36.54M13.55%16.8M563.28%16.96M339.98%18.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More